Dr. David Silbert, MD
NPI: 1275593295
Total Payments
$26,847
2024 Payments
$485.71
Companies
27
Transactions
72
Medicare Patients
3,451
Medicare Billing
$505,076
Payment Breakdown by Category
Other$14,711 (54.8%)
Gifts$8,037 (29.9%)
Travel$2,152 (8.0%)
Food & Beverage$1,859 (6.9%)
Consulting$45.00 (0.2%)
Education$42.90 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $14,465 | 4 | 53.9% |
| Gift | $8,037 | 8 | 29.9% |
| Travel and Lodging | $2,152 | 5 | 8.0% |
| Food and Beverage | $1,859 | 50 | 6.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $246.38 | 1 | 0.9% |
| Consulting Fee | $45.00 | 1 | 0.2% |
| Education | $42.90 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $16,932 | 26 | $0 (2022) |
| Kaneka Pharma America LLC | $6,660 | 7 | $0 (2018) |
| Quest Medical Inc. | $1,377 | 1 | $0 (2017) |
| iScreen Vision Inc. | $500.00 | 1 | $0 (2017) |
| Notal Vision, Inc. | $246.38 | 1 | $0 (2022) |
| Shire North American Group Inc | $160.72 | 3 | $0 (2019) |
| Tarsus Pharmaceuticals, Inc. | $148.72 | 6 | $0 (2024) |
| Alcon Vision LLC | $120.53 | 1 | $0 (2024) |
| Carl Zeiss Meditec USA, Inc. | $102.67 | 1 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $97.15 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $485.71 | 13 | Tarsus Pharmaceuticals, Inc. ($148.72) |
| 2023 | $67.85 | 4 | Organogenesis Inc. ($32.03) |
| 2022 | $454.74 | 8 | Notal Vision, Inc. ($246.38) |
| 2021 | $104.92 | 5 | Alexion Pharmaceuticals, Inc. ($27.36) |
| 2020 | $16,786 | 23 | Horizon Therapeutics plc ($16,759) |
| 2019 | $237.82 | 5 | Shire North American Group Inc ($119.74) |
| 2018 | $4,559 | 5 | Kaneka Pharma America LLC ($4,440) |
| 2017 | $4,151 | 9 | Kaneka Pharma America LLC ($2,220) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $35.27 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/05/2024 | Carl Zeiss Meditec USA, Inc. | CIRRUS HD-OCT (Device) | Food and Beverage | In-kind items and services | $102.67 | General |
| Category: Optical Tomography | ||||||
| 09/26/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $32.21 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/05/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $120.53 | General |
| Category: Ophthalmology | ||||||
| 06/04/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 03/18/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Ophthalmology | ||||||
| 03/04/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/28/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $37.49 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 02/22/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $39.72 | General |
| Category: IMMUNOLOGY | ||||||
| 02/06/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 01/31/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 01/25/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $3.40 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/25/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $15.63 | General |
| Category: Wound Care | ||||||
| 09/13/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: IMMUNOLOGY | ||||||
| 04/05/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $22.88 | General |
| 02/01/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $16.40 | General |
| Category: Wound Care | ||||||
| 10/26/2022 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $28.09 | General |
| Category: WOUND CARE | ||||||
| 10/23/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: TEPEZZA | ||||||
| 10/06/2022 | Notal Vision, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $246.38 | General |
| 09/29/2022 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $37.30 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 07/28/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/24/2022 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $48.29 | General |
| 04/01/2022 | BioTissue Holdings, Inc. | NEOX (Medical Supply), CLARIX | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 01/25/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: TEPEZZA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,022 | 1,104 | $710,757 | $143,565 |
| 2022 | 16 | 979 | 3,971 | $690,306 | $152,076 |
| 2021 | 16 | 698 | 805 | $482,421 | $106,257 |
| 2020 | 16 | 752 | 858 | $488,935 | $103,178 |
Total Patients
3,451
Total Services
6,738
Medicare Billing
$505,076
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2023 | 55 | 55 | $170,400 | $31,975 | 18.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 206 | 206 | $57,680 | $24,266 | 42.1% |
| 67900 | Repair of brow paralysis | Facility | 2023 | 39 | 39 | $108,000 | $10,828 | 10.0% |
| 68801 | Dilation of tear drainage opening | Office | 2023 | 67 | 102 | $43,500 | $9,204 | 21.2% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2023 | 16 | 16 | $52,000 | $9,098 | 17.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 99 | $22,275 | $8,609 | 38.6% |
| 67908 | Removal of tissue, muscle, and membrane to correct eyelid drooping or paralysis | Facility | 2023 | 23 | 24 | $72,000 | $7,856 | 10.9% |
| 67840 | Removal of growth of eyelid | Office | 2023 | 34 | 35 | $23,650 | $7,625 | 32.2% |
| 67917 | Extensive repair of turning-outward eyelid defect | Facility | 2023 | 15 | 16 | $46,400 | $7,465 | 16.1% |
| 67917 | Extensive repair of turning-outward eyelid defect | Office | 2023 | 12 | 12 | $24,000 | $6,362 | 26.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 100 | $17,500 | $6,297 | 36.0% |
| 92285 | Photography of content of eyes | Office | 2023 | 255 | 268 | $13,400 | $4,207 | 31.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 41 | 41 | $8,077 | $3,384 | 41.9% |
| 68815 | Probing of nasal tear duct with insertion of tube or stent | Facility | 2023 | 23 | 24 | $36,000 | $2,668 | 7.4% |
| 11440 | Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 15 | 15 | $4,000 | $1,303 | 32.6% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2023 | 20 | 25 | $2,875 | $1,147 | 39.9% |
| 68440 | Snip incision of tear duct at inner corner of eye | Facility | 2023 | 15 | 15 | $5,750 | $729.51 | 12.7% |
| 30930 | Therapeutic fracture of nasal passages | Facility | 2023 | 12 | 12 | $3,250 | $541.20 | 16.7% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2022 | 49 | 49 | $150,400 | $29,385 | 19.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 248 | 248 | $69,440 | $28,789 | 41.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 12 | 2,891 | $34,976 | $13,896 | 39.7% |
| 67900 | Repair of brow paralysis | Facility | 2022 | 43 | 43 | $117,000 | $12,937 | 11.1% |
| 67840 | Removal of growth of eyelid | Office | 2022 | 49 | 51 | $27,800 | $11,777 | 42.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 100 | $22,500 | $9,222 | 41.0% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2022 | 15 | 15 | $50,000 | $8,529 | 17.1% |
About Dr. David Silbert, MD
Dr. David Silbert, MD is a Pediatric Ophthalmology and Strabismus Specialist healthcare provider based in Lancaster, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275593295.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Silbert, MD has received a total of $26,847 in payments from pharmaceutical and medical device companies, with $485.71 received in 2024. These payments were reported across 72 transactions from 27 companies. The most common payment nature is "Honoraria" ($14,465).
As a Medicare-enrolled provider, Silbert has provided services to 3,451 Medicare beneficiaries, totaling 6,738 services with total Medicare billing of $505,076. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatric Ophthalmology and Strabismus Specialist
- Other Specialties Ophthalmology
- Location Lancaster, PA
- Active Since 03/24/2006
- Last Updated 08/12/2022
- Taxonomy Code 207WX0110X
- Entity Type Individual
- NPI Number 1275593295
Products in Payments
- TEPEZZA (Drug) $15,636
- Lacriflow (Medical Supply) $6,660
- XIIDRA (Drug) $175.44
- XDEMVY (Drug) $148.72
- Clareon (Device) $120.53
- CIRRUS HD-OCT (Device) $102.67
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $97.15
- Puraply (Medical Supply) $60.12
- DEXTENZA (Drug) $53.85
- ACTHAR (Biological) $52.66
- TEPEZZA (Biological) $43.22
- EYLEA (Biological) $27.39
- Soliris (Drug) $27.36
- INVELTYS (Drug) $23.28
- NEOX (Medical Supply) $22.29
- DARAPRIM (Drug) $21.29
- VUITY (Drug) $18.93
- IYUZEH (Drug) $17.31
- Avenova (Device) $13.63
- VYZULTA (Drug) $13.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.